Bulk - wakix 17.8MG tab
Ended Awarded Last action
- Contract number
- 36C26026F0062
- Awardee
-
Harmony Biosciences LLC UEI TD8KAL6BNW67
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $635,245
Award facts
- Contract value 100% obligated
- $635,244.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $15,365 | |
| Original award | $619,879 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20 (VISN 20), awarded a $635,244.75 firm fixed-price delivery order to Harmony Biosciences LLC on December 1, 2025, for the bulk supply of WAKIX (pitolisant) 17.8 mg tablets, including a 2026 price increase. This delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 30, 2026. The award falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a continuation of Harmony Biosciences' ongoing supply relationship with the VA, leveraging a larger $25 million blanket purchase agreement established in June 2025 that streamlines procurement across multiple VISNs nationwide.
WAKIX is a specialized pharmaceutical indicated for treating excessive daytime sleepiness and cataplexy in adult patients with narcolepsy, addressing a critical healthcare need within the veteran population served by the VA system. Harmony Biosciences LLC, a Pennsylvania-based pharmaceutical company specializing in rare neurological diseases and sleep disorders, serves as the prime contractor with no identified subcontractors. Performance will take place at the vendor's location in Plymouth Meeting, Pennsylvania, with distribution to VA medical centers throughout the healthcare system. The delivery order structure provides the flexibility necessary to ensure consistent supply availability of this specialized medication to veteran patients requiring narcolepsy treatment across the VA's integrated service network.
Quick answers
Who was awarded contract 36C26026F0062?
36C26026F0062 was awarded to Harmony Biosciences LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 1, 2025.
How much is contract 36C26026F0062 worth?
The government has obligated $635,245 on 36C26026F0062.
Is contract 36C26026F0062 an order under another contract?
Yes. 36C26026F0062 is a delivery order under 36F79720D0148, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26026F0062 competed?
The extent of competition for 36C26026F0062 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award